Research, Development, Innovation

Research at Bayer

Research at Bayer

With strong and efficient research and development (R&D), a focus on growth areas and the Emerging Markets, and a national and international network of outstanding partners, we are creating the foundation for innovation and thus the company’s future success. In 2013 a total of €3,190 million (2012: €3,013 million) was spent on research and development. This was equivalent to 7.9% (2012: 7.6%) of sales. The number of employees working in research and development worldwide was 13,700.

Research collaborations with external partners from academia and industry form an integral part of our innovation strategy. These collaborations and alliances with leading universities, public research institutes and partner companies are supplemented by incubators, crowdsourcing and science hubs in Asia and the United States to tap into external innovative potential using the open innovation approach. Some of our collaborations are supported by public funding.

Reliable, global protection of intellectual property rights is essential for an innovation company like Bayer. At the end of 2013, we owned approximately 67,400 valid patent applications and patents worldwide relating to some 8,700 protected inventions.

Innovation Areas of the Bayer Group

Research beyond Borders

Strengthening Research in the Life Sciences
Bayer is the only global company simultaneously researching improvements in human, animal and plant health. Systematic and intensive collaboration among researchers from both Life Science subgroups is providing new impetus. In this context, researchers from HealthCare and CropScience are collaborating on projects involving central biological processes such as gene regulation or energy metabolism. The joint use of technology platforms is being expanded. These projects have been supported since 2012 by Bayer’s internal “Life Sciences Fund” and are mostly implemented together with external partners.

Research spending

Research Spending

In Germany alone, Bayer participated in more than 100 publicly funded projects in 2013, receiving a total of about €8 million in grants. This is equivalent to roughly 0.3% of our annual R&D expenses.

Research and Development Expenses 2010

Research and Development expenses 2013
by subgroup in %

Research and Development expenses 2013
by subgroup in EUR million

Research and Development Expenses 2010
Last updated: September 24, 2014 Copyright © Bayer AG